SCHEMBL12840289

SCHEMBL12840289

Cc1nc2c(nc1NC(=O)c1ccccc1)CCc1cc(N)ccc1-2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.45
MAPT P10636 6/20 0.45
CYP2C19 P33261 5/20 0.45
CYP2C9 P11712 4/20 0.45
CYP3A4 P08684 5/20 0.43
GAA P10253 2/20 0.43
P2RX3 P56373 1/20 0.40
NPC1 O15118 5/20 0.39
KDM4E B2RXH2 5/20 0.39
RAB9A P51151 4/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
APAF1 O14727 1/20 0.39
MAPK14 Q16539 5/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12839735 0.88 TYR (0.45) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12838754 0.87 CYP1A2 (0.43) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12840216 0.87 CYP1A2 (0.43) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12840305 0.86 HSD17B10 (0.38) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12839572 0.86 CYP1A2 (0.41) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12840502 0.86 CYP1A2 (0.54) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL13067608 0.85 IKBKB (0.43) GAANPC1KDM4ERAB9AHPGD
SCHEMBL12838713 0.85 MAPT (0.56) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12840664 0.85 L3MBTL1 (0.41) CYP1A2MAPTCYP2C19CYP2C9CYP3A4
SCHEMBL12839410 0.85 CYP1A2 (0.40) CYP1A2MAPTCYP2C19CYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed
EP-1666488-B1 FLUORESCENT PROTEIN CHISSO CORP (JP) 2010-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 CYP1A2 4017/4885MAPT 3847/4885CYP2C19 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.